Replies to post #81 on China BioPharma Corp (fka CHBO)

[Ca/apul/]

CBPC to Appear On MN1.com at 1:00PM EST.



PRINCETON, N.J.--(BUSINESS WIRE)--Peter Wang, CEO, of China Biopharma, Inc.(OTCBB:CBPC - News), will be featured live on Market News First (www.mn1.com) for an exclusive interview with the MN1 news team. The interview is scheduled for Dec. 05, 2006, at 1:00PM EST.



China Biopharma Inc. (OTCBB:CBPC - News) is a fast-growing biopharmaceutical company based in China. Through its operating subsidiaries, Zhejiang Tianyuan Biotech Co., Ltd. and Hainan CITIC Biopharmaceutical Development Co., Ltd., the Company develops and distributes human vaccine products throughout the world's most populated country of China. Products include human vaccines against influenza, hemorrhagic fever and Japanese Encephalitis. Leveraging its investment and ownership of local Chinese biopharmaceutical companies, and partnerships with international vaccine providers, China Biopharma is building a highly-competitive platform for growth in China as well as new markets, including the U.S. and Europe. For more information, visit its website at http://www.chinabiopharma.com.cn.